Double Bonus continued: An Interview with Pediatric Hematologist, Dr. Gregory Yanik PART 2

Waiting is the Hardest (W.I.T.H Podcast 🎙)

We wrap up our conversation with Dr. Gregory Yanik, Director of the Pediatric Blood and Marrow Transplant Program at the University of Michigan Medical Center in Ann Arbor, Michigan.
Parts 1 and 2 of this double bonus episode is a must-listen for every patient, family, and doctor in the healthcare field. Dr. Yanik epitomizes a model of compassion and respect for families and patients that every healthcare center should replicate and implement ASAP.
This episode covers graft versus host disease, patient advocacy, the latest in half and full-match bone marrow transplant options for patients with sickle cell anemia, gene editing, recently completed studies from the Bone Marrow Transplant Clinical Trial Network, and much more!

Capitoli

1. Double Bonus continued: An Interview with Pediatric Hematologist, Dr. Gregory Yanik PART 2 (00:00:00)

2. Graft v Host disease risks (00:01:47)

3. What is Graft versus Host Disease (GVHD) (00:04:16)

4. Center Us: GVHD in black patients (00:06:13)

5. CORRECTION: GVHD is inflammation NOT rejection (00:06:20)

6. Types of GVHD (00:09:07)

7. Rejection rates: Sickle Cell Disease and Transplant (00:12:16)

8. Research studies (00:13:40)

9. Bone Marrow Transplant Clinical Trial Network (BMTCTN) (00:14:10)

10. Completing the patient care puzzle: Patient advocacy (00:18:05)

11. Adult patients with sickle cell anemia (00:22:00)

12. Gene editing (00:23:10)

13. DNA scissors (00:23:37)

14. Fetal hemoglobin (00:23:50)

15. Gene editing: Becoming part of a clinical trial (00:25:36)

16. Sickle Cell Disease Treatment Centers Act of 2022 (00:29:25)

17. Dr. Yanik's words of encouragement (00:31:20)